Antiretroviral therapy initiation timing
1 paper1 finding
- 1 lab in 1 country
- Funders: Gilead Sciences and 7 more
- Humans1
Outcomes
1Framingham risk score
no changein humans1
1 study
Framingham risk score
no changein humans1
Antiretroviral therapy initiation timing has no effect on Framingham risk score in humans.
“However, in matched cohorts, no differences were found in FRS-based outcomes.”
Humansafter 6 years of ART in age- and gender-matched cohorts6 yearsmatcheds
HIV medicine21 Feb 2024
Latest
HIV Medicine
Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART
Cohort study in peopleFramingham risk score